

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 9.71427818 |
| 2 | sarcomere organization (GO:0045214) | 8.80816804 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.65713334 |
| 4 | muscle filament sliding (GO:0030049) | 8.65713334 |
| 5 | myofibril assembly (GO:0030239) | 8.27662950 |
| 6 | cardiac muscle tissue morphogenesis (GO:0055008) | 7.68039147 |
| 7 | cardiac muscle hypertrophy (GO:0003300) | 7.67467991 |
| 8 | cardiac muscle contraction (GO:0060048) | 7.66713941 |
| 9 | heart contraction (GO:0060047) | 7.54118626 |
| 10 | heart process (GO:0003015) | 7.54118626 |
| 11 | actin-mediated cell contraction (GO:0070252) | 7.28988766 |
| 12 | striated muscle hypertrophy (GO:0014897) | 7.24282513 |
| 13 | potassium ion export (GO:0071435) | 7.09801654 |
| 14 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 7.07587318 |
| 15 | cardiac muscle cell development (GO:0055013) | 7.02079886 |
| 16 | muscle tissue morphogenesis (GO:0060415) | 6.83115739 |
| 17 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.80067671 |
| 18 | cardiac cell development (GO:0055006) | 6.62358237 |
| 19 | regulation of sarcomere organization (GO:0060297) | 6.55364673 |
| 20 | muscle hypertrophy (GO:0014896) | 6.45647038 |
| 21 | regulation of relaxation of muscle (GO:1901077) | 6.40438156 |
| 22 | ATP synthesis coupled proton transport (GO:0015986) | 6.28396468 |
| 23 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.28396468 |
| 24 | adult heart development (GO:0007512) | 6.22273715 |
| 25 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.12542498 |
| 26 | actomyosin structure organization (GO:0031032) | 6.08035414 |
| 27 | tricarboxylic acid cycle (GO:0006099) | 5.94536815 |
| 28 | heart trabecula formation (GO:0060347) | 5.78013711 |
| 29 | detection of calcium ion (GO:0005513) | 5.77925583 |
| 30 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 5.73448870 |
| 31 | muscle hypertrophy in response to stress (GO:0003299) | 5.73448870 |
| 32 | cardiac muscle adaptation (GO:0014887) | 5.73448870 |
| 33 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 5.69495686 |
| 34 | striated muscle contraction (GO:0006941) | 5.67313726 |
| 35 | regulation of cardioblast differentiation (GO:0051890) | 5.65025373 |
| 36 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.54623303 |
| 37 | oxidative phosphorylation (GO:0006119) | 5.54506067 |
| 38 | regulation of the force of heart contraction (GO:0002026) | 5.54424480 |
| 39 | cardiac ventricle formation (GO:0003211) | 5.44075195 |
| 40 | regulation of actin filament-based movement (GO:1903115) | 5.41532026 |
| 41 | regulation of cell communication by electrical coupling (GO:0010649) | 5.40982218 |
| 42 | actin filament-based movement (GO:0030048) | 5.39187842 |
| 43 | ventricular cardiac muscle cell development (GO:0055015) | 5.10406532 |
| 44 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 5.06335808 |
| 45 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.97174008 |
| 46 | respiratory electron transport chain (GO:0022904) | 4.92953926 |
| 47 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.92003928 |
| 48 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.82455805 |
| 49 | electron transport chain (GO:0022900) | 4.80882084 |
| 50 | regulation of striated muscle contraction (GO:0006942) | 4.80646007 |
| 51 | regulation of skeletal muscle contraction (GO:0014819) | 4.77969906 |
| 52 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.74669165 |
| 53 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.68029622 |
| 54 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 4.55179936 |
| 55 | negative regulation of heart growth (GO:0061117) | 4.55179936 |
| 56 | regulation of ATPase activity (GO:0043462) | 4.53986535 |
| 57 | regulation of ATP catabolic process (GO:1903289) | 4.53986535 |
| 58 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.49306184 |
| 59 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.45806559 |
| 60 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.20957520 |
| 61 | atrioventricular valve morphogenesis (GO:0003181) | 4.17413925 |
| 62 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.17128061 |
| 63 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.17075761 |
| 64 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.14243730 |
| 65 | NADH metabolic process (GO:0006734) | 4.13936429 |
| 66 | ATP biosynthetic process (GO:0006754) | 4.12677574 |
| 67 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.12256336 |
| 68 | endocardial cushion development (GO:0003197) | 4.04538180 |
| 69 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 4.01976307 |
| 70 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.93014014 |
| 71 | atrial septum morphogenesis (GO:0060413) | 3.91971661 |
| 72 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.91688327 |
| 73 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.88054173 |
| 74 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.86943978 |
| 75 | regulation of lipoprotein metabolic process (GO:0050746) | 3.82611168 |
| 76 | trabecula formation (GO:0060343) | 3.81404130 |
| 77 | regulation of cardioblast proliferation (GO:0003264) | 3.80422176 |
| 78 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.80422176 |
| 79 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.80253285 |
| 80 | striated muscle adaptation (GO:0014888) | 3.78532889 |
| 81 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.76631038 |
| 82 | striated muscle cell development (GO:0055002) | 3.74185955 |
| 83 | carnitine shuttle (GO:0006853) | 3.72814839 |
| 84 | positive regulation of cardiac muscle tissue development (GO:0055025) | 3.72019384 |
| 85 | cardiac right ventricle morphogenesis (GO:0003215) | 3.70684077 |
| 86 | negative regulation of protein localization to cell surface (GO:2000009) | 3.68319430 |
| 87 | cardiac chamber formation (GO:0003207) | 3.67521902 |
| 88 | outflow tract septum morphogenesis (GO:0003148) | 3.66426711 |
| 89 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.65223603 |
| 90 | regulation of cofactor metabolic process (GO:0051193) | 3.64685210 |
| 91 | regulation of coenzyme metabolic process (GO:0051196) | 3.64685210 |
| 92 | cell communication involved in cardiac conduction (GO:0086065) | 3.57518319 |
| 93 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.57098147 |
| 94 | cytidine metabolic process (GO:0046087) | 3.55148451 |
| 95 | cytidine catabolic process (GO:0006216) | 3.55148451 |
| 96 | cytidine deamination (GO:0009972) | 3.55148451 |
| 97 | atrial cardiac muscle cell action potential (GO:0086014) | 3.53204268 |
| 98 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.51263728 |
| 99 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.51126589 |
| 100 | regulation of heart rate (GO:0002027) | 3.50304751 |
| 101 | cell communication by electrical coupling (GO:0010644) | 3.49788707 |
| 102 | regulation of membrane repolarization (GO:0060306) | 3.49304333 |
| 103 | plasma membrane repair (GO:0001778) | 3.49167959 |
| 104 | regulation of cardiac muscle contraction (GO:0055117) | 3.48041247 |
| 105 | cardiac muscle tissue development (GO:0048738) | 3.47788982 |
| 106 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.45321484 |
| 107 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.44829895 |
| 108 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.44829895 |
| 109 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.42770890 |
| 110 | positive regulation of ATP catabolic process (GO:1903291) | 3.42755561 |
| 111 | positive regulation of ATPase activity (GO:0032781) | 3.42755561 |
| 112 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.42169974 |
| 113 | regulation of muscle contraction (GO:0006937) | 3.41343212 |
| 114 | regulation of heart contraction (GO:0008016) | 3.40927775 |
| 115 | response to inactivity (GO:0014854) | 3.39026774 |
| 116 | positive regulation of heart growth (GO:0060421) | 3.36294354 |
| 117 | cardiac muscle cell action potential (GO:0086001) | 3.34822596 |
| 118 | cardiac conduction (GO:0061337) | 3.33829289 |
| 119 | cell migration involved in heart development (GO:0060973) | 3.26816538 |
| 120 | negative regulation of heart rate (GO:0010459) | 3.26377840 |
| 121 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.25908836 |
| 122 | positive regulation of sodium ion transport (GO:0010765) | 3.25804312 |
| 123 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.25580151 |
| 124 | neuronal ion channel clustering (GO:0045161) | 3.24518491 |
| 125 | regulation of cardiac muscle tissue growth (GO:0055021) | 3.23828609 |
| 126 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.23825939 |
| 127 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.22750496 |
| 128 | negative regulation of potassium ion transport (GO:0043267) | 3.18392632 |
| 129 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.15622519 |
| 130 | positive regulation of action potential (GO:0045760) | 3.11004162 |
| 131 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.11000260 |
| 132 | positive regulation of heart contraction (GO:0045823) | 3.09537782 |
| 133 | membrane repolarization (GO:0086009) | 3.06182397 |
| 134 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.05581323 |
| 135 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.05581323 |
| 136 | regulation of cation channel activity (GO:2001257) | 3.05083640 |
| 137 | protein maturation by protein folding (GO:0022417) | 2.89832290 |
| 138 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.87782190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.79806605 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 6.71285282 |
| 3 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 6.28000057 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.68454235 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.04212173 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.88949657 |
| 7 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 4.67211097 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.28845233 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.15115662 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.98142964 |
| 11 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.88832966 |
| 12 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.88832966 |
| 13 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 3.45930635 |
| 14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.41309258 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.29969928 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 3.29163724 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.10933282 |
| 18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.92515800 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.91530771 |
| 20 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.69140791 |
| 21 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.57819047 |
| 22 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.49223185 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.43141087 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.42852320 |
| 25 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.38978825 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 2.33581402 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.23596066 |
| 28 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 2.21849854 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12872373 |
| 30 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.11537136 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.10434347 |
| 32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.85870045 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85494401 |
| 34 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.77440709 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76557975 |
| 36 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.75820756 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.73227789 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.73010677 |
| 39 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.68580482 |
| 40 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.67823301 |
| 41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.67603887 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61810544 |
| 43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.60006106 |
| 44 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.59353373 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.55613917 |
| 46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.51840174 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45674883 |
| 48 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.43640618 |
| 49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38411642 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37297157 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35799677 |
| 52 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.31919392 |
| 53 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.31647877 |
| 54 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31391863 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30066381 |
| 56 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.30028692 |
| 57 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.29721388 |
| 58 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.29568076 |
| 59 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29405446 |
| 60 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.27213688 |
| 61 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.26730416 |
| 62 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.26137928 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23649706 |
| 64 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20498351 |
| 65 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.20117263 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18159001 |
| 67 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18114600 |
| 68 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.12171144 |
| 69 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11744965 |
| 70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.09781099 |
| 71 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02119823 |
| 72 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01790589 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01123142 |
| 74 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00381578 |
| 75 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.00027712 |
| 76 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.00027712 |
| 77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99450643 |
| 78 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99387794 |
| 79 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.98693427 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97283858 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96675546 |
| 82 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96670549 |
| 83 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.96565011 |
| 84 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.96414885 |
| 85 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.95998576 |
| 86 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.95939912 |
| 87 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95642482 |
| 88 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95326576 |
| 89 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94808210 |
| 90 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94324917 |
| 91 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.94105983 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93703612 |
| 93 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93528618 |
| 94 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.92412937 |
| 95 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91687393 |
| 96 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.90929592 |
| 97 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88097463 |
| 98 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87610913 |
| 99 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.86764213 |
| 100 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.86685979 |
| 101 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.85792459 |
| 102 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.85366970 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84723166 |
| 104 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84648025 |
| 105 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.84289208 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83448172 |
| 107 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.82038898 |
| 108 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.81721088 |
| 109 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.81538951 |
| 110 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.80276327 |
| 111 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.79693178 |
| 112 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.79619991 |
| 113 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78870742 |
| 114 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.78754119 |
| 115 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.78669056 |
| 116 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.78469225 |
| 117 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.78254016 |
| 118 | CBP_21632823_ChIP-Seq_H3396_Human | 0.76808084 |
| 119 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.76420133 |
| 120 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.75912976 |
| 121 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75868718 |
| 122 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.75628788 |
| 123 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.75610907 |
| 124 | NCOR_22424771_ChIP-Seq_293T_Human | 0.75243166 |
| 125 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.75001921 |
| 126 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.74986862 |
| 127 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.74567674 |
| 128 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.73443359 |
| 129 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.73340549 |
| 130 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.73070709 |
| 131 | GATA1_19941826_ChIP-Seq_K562_Human | 0.72377126 |
| 132 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71999611 |
| 133 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70508369 |
| 134 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.70412360 |
| 135 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.68910733 |
| 136 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.68899428 |
| 137 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.68447107 |
| 138 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.68247928 |
| 139 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.67827442 |
| 140 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.67567725 |
| 141 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.67237361 |
| 142 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.66474518 |
| 143 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.66374242 |
| 144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63613549 |
| 145 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.63421292 |
| 146 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.62171124 |
| 147 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.61910485 |
| 148 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.60762788 |
| 149 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.59130377 |
| 150 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.58804449 |
| 151 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.57685557 |
| 152 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.57655410 |
| 153 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.57119646 |
| 154 | CJUN_26792858_Chip-Seq_BT549_Human | 0.56323282 |
| 155 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.55618476 |
| 156 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.55554194 |
| 157 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.55463127 |
| 158 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.55246138 |
| 159 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.54927217 |
| 160 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.54826096 |
| 161 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.54747725 |
| 162 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.53924662 |
| 163 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.53410831 |
| 164 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.52667783 |
| 165 | ERA_21632823_ChIP-Seq_H3396_Human | 0.52303727 |
| 166 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.52216056 |
| 167 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.50743968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 6.69651534 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.20255311 |
| 3 | MP0000749_muscle_degeneration | 4.68015162 |
| 4 | MP0004036_abnormal_muscle_relaxation | 4.65780522 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.33682224 |
| 6 | MP0005330_cardiomyopathy | 4.12581439 |
| 7 | MP0000751_myopathy | 3.93688232 |
| 8 | MP0002972_abnormal_cardiac_muscle | 3.75698677 |
| 9 | MP0008775_abnormal_heart_ventricle | 3.74822850 |
| 10 | MP0003646_muscle_fatigue | 3.65490701 |
| 11 | MP0003828_pulmonary_edema | 3.00085536 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.99126813 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.97056585 |
| 14 | MP0010630_abnormal_cardiac_muscle | 2.95975880 |
| 15 | MP0006138_congestive_heart_failure | 2.90300815 |
| 16 | MP0001544_abnormal_cardiovascular_syste | 2.89941020 |
| 17 | MP0005385_cardiovascular_system_phenoty | 2.89941020 |
| 18 | MP0005620_abnormal_muscle_contractility | 2.78432760 |
| 19 | MP0003221_abnormal_cardiomyocyte_apopto | 2.72613791 |
| 20 | MP0004085_abnormal_heartbeat | 2.63178456 |
| 21 | MP0004510_myositis | 2.47655888 |
| 22 | MP0002127_abnormal_cardiovascular_syste | 2.37086948 |
| 23 | MP0002106_abnormal_muscle_physiology | 2.23203891 |
| 24 | MP0004484_altered_response_of | 2.19678961 |
| 25 | MP0005451_abnormal_body_composition | 2.12407716 |
| 26 | MP0002269_muscular_atrophy | 2.11748812 |
| 27 | MP0004145_abnormal_muscle_electrophysio | 2.08476546 |
| 28 | MP0003950_abnormal_plasma_membrane | 2.07292175 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 2.04758545 |
| 30 | MP0008004_abnormal_stomach_pH | 2.01752284 |
| 31 | MP0002822_catalepsy | 1.96545078 |
| 32 | MP0003567_abnormal_fetal_cardiomyocyte | 1.95941781 |
| 33 | MP0000750_abnormal_muscle_regeneration | 1.93608476 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.86912892 |
| 35 | MP0005369_muscle_phenotype | 1.78746951 |
| 36 | MP0003787_abnormal_imprinting | 1.74034708 |
| 37 | MP0002653_abnormal_ependyma_morphology | 1.64081317 |
| 38 | MP0003122_maternal_imprinting | 1.55370155 |
| 39 | MP0000747_muscle_weakness | 1.54397156 |
| 40 | MP0008877_abnormal_DNA_methylation | 1.54161941 |
| 41 | MP0000759_abnormal_skeletal_muscle | 1.51885993 |
| 42 | MP0003011_delayed_dark_adaptation | 1.44405579 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.43756066 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.39723604 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.37571301 |
| 46 | MP0000266_abnormal_heart_morphology | 1.34980530 |
| 47 | MP0004233_abnormal_muscle_weight | 1.33940306 |
| 48 | MP0004130_abnormal_muscle_cell | 1.33095059 |
| 49 | MP0001529_abnormal_vocalization | 1.28985018 |
| 50 | MP0004270_analgesia | 1.20765757 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.18447753 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.17801222 |
| 53 | MP0004272_abnormal_basement_membrane | 1.17678380 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.11731557 |
| 55 | MP0005083_abnormal_biliary_tract | 1.10923318 |
| 56 | MP0003941_abnormal_skin_development | 1.08798598 |
| 57 | MP0003880_abnormal_central_pattern | 1.06805496 |
| 58 | MP0001968_abnormal_touch/_nociception | 1.06637370 |
| 59 | MP0009745_abnormal_behavioral_response | 1.06305857 |
| 60 | MP0003279_aneurysm | 1.06056441 |
| 61 | MP0000343_altered_response_to | 1.05826080 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.02797369 |
| 63 | MP0002736_abnormal_nociception_after | 0.98945201 |
| 64 | MP0002234_abnormal_pharynx_morphology | 0.98635615 |
| 65 | MP0000230_abnormal_systemic_arterial | 0.95359981 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 0.94792616 |
| 67 | MP0002735_abnormal_chemical_nociception | 0.88971599 |
| 68 | MP0009384_cardiac_valve_regurgitation | 0.84350032 |
| 69 | MP0005266_abnormal_metabolism | 0.84025817 |
| 70 | MP0000013_abnormal_adipose_tissue | 0.83558324 |
| 71 | MP0002088_abnormal_embryonic_growth/wei | 0.83424670 |
| 72 | MP0002128_abnormal_blood_circulation | 0.83294610 |
| 73 | MP0003879_abnormal_hair_cell | 0.82837781 |
| 74 | MP0003984_embryonic_growth_retardation | 0.82376528 |
| 75 | MP0001986_abnormal_taste_sensitivity | 0.80791084 |
| 76 | MP0002090_abnormal_vision | 0.79314043 |
| 77 | MP0005423_abnormal_somatic_nervous | 0.78207113 |
| 78 | MP0004924_abnormal_behavior | 0.77447142 |
| 79 | MP0005386_behavior/neurological_phenoty | 0.77447142 |
| 80 | MP0005448_abnormal_energy_balance | 0.77392781 |
| 81 | MP0002272_abnormal_nervous_system | 0.76472627 |
| 82 | MP0002925_abnormal_cardiovascular_devel | 0.75865339 |
| 83 | MP0008874_decreased_physiological_sensi | 0.74682939 |
| 84 | MP0002064_seizures | 0.73353815 |
| 85 | MP0001984_abnormal_olfaction | 0.73317580 |
| 86 | MP0003123_paternal_imprinting | 0.73188283 |
| 87 | MP0005165_increased_susceptibility_to | 0.72658938 |
| 88 | MP0000767_abnormal_smooth_muscle | 0.72533695 |
| 89 | MP0005253_abnormal_eye_physiology | 0.71957435 |
| 90 | MP0010368_abnormal_lymphatic_system | 0.69888568 |
| 91 | MP0002971_abnormal_brown_adipose | 0.68260901 |
| 92 | MP0009697_abnormal_copulation | 0.67085503 |
| 93 | MP0004133_heterotaxia | 0.66421464 |
| 94 | MP0003121_genomic_imprinting | 0.64215279 |
| 95 | MP0002063_abnormal_learning/memory/cond | 0.64070926 |
| 96 | MP0002163_abnormal_gland_morphology | 0.63865595 |
| 97 | MP0001970_abnormal_pain_threshold | 0.62275915 |
| 98 | MP0001905_abnormal_dopamine_level | 0.61640255 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.60688202 |
| 100 | MP0003878_abnormal_ear_physiology | 0.60688202 |
| 101 | MP0005379_endocrine/exocrine_gland_phen | 0.60415689 |
| 102 | MP0003953_abnormal_hormone_level | 0.60077929 |
| 103 | MP0006072_abnormal_retinal_apoptosis | 0.60049916 |
| 104 | MP0002693_abnormal_pancreas_physiology | 0.59972839 |
| 105 | MP0002572_abnormal_emotion/affect_behav | 0.58999471 |
| 106 | MP0002133_abnormal_respiratory_system | 0.58593538 |
| 107 | MP0005388_respiratory_system_phenotype | 0.58593538 |
| 108 | MP0008875_abnormal_xenobiotic_pharmacok | 0.58042720 |
| 109 | MP0001672_abnormal_embryogenesis/_devel | 0.56343259 |
| 110 | MP0005380_embryogenesis_phenotype | 0.56343259 |
| 111 | MP0001944_abnormal_pancreas_morphology | 0.56211405 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.55493196 |
| 113 | MP0001784_abnormal_fluid_regulation | 0.55171907 |
| 114 | MP0005535_abnormal_body_temperature | 0.55046551 |
| 115 | MP0004147_increased_porphyrin_level | 0.53663082 |
| 116 | MP0003635_abnormal_synaptic_transmissio | 0.53112071 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.52296831 |
| 118 | MP0001614_abnormal_blood_vessel | 0.51612062 |
| 119 | MP0002733_abnormal_thermal_nociception | 0.51142914 |
| 120 | MP0001730_embryonic_growth_arrest | 0.48523539 |
| 121 | MP0005670_abnormal_white_adipose | 0.47210735 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.45703135 |
| 123 | MP0004043_abnormal_pH_regulation | 0.44490265 |
| 124 | MP0005595_abnormal_vascular_smooth | 0.44421606 |
| 125 | MP0003115_abnormal_respiratory_system | 0.42624797 |
| 126 | MP0005503_abnormal_tendon_morphology | 0.40679441 |
| 127 | MP0001175_abnormal_lung_morphology | 0.39799146 |
| 128 | MP0005171_absent_coat_pigmentation | 0.39749741 |
| 129 | MP0002108_abnormal_muscle_morphology | 0.39270466 |
| 130 | MP0000762_abnormal_tongue_morphology | 0.36364061 |
| 131 | MP0001697_abnormal_embryo_size | 0.36250948 |
| 132 | MP0002132_abnormal_respiratory_system | 0.36071659 |
| 133 | MP0002933_joint_inflammation | 0.35957844 |
| 134 | MP0008438_abnormal_cutaneous_collagen | 0.34970420 |
| 135 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.34504039 |
| 136 | MP0003186_abnormal_redox_activity | 0.34257519 |
| 137 | MP0003948_abnormal_gas_homeostasis | 0.33742277 |
| 138 | MP0003119_abnormal_digestive_system | 0.31840523 |
| 139 | MP0002086_abnormal_extraembryonic_tissu | 0.31211944 |
| 140 | MP0005319_abnormal_enzyme/_coenzyme | 0.30708646 |
| 141 | MP0005623_abnormal_meninges_morphology | 0.27128494 |
| 142 | MP0003385_abnormal_body_wall | 0.26814343 |
| 143 | MP0002282_abnormal_trachea_morphology | 0.26067054 |
| 144 | MP0000537_abnormal_urethra_morphology | 0.24703728 |
| 145 | MP0005332_abnormal_amino_acid | 0.24466908 |
| 146 | MP0005375_adipose_tissue_phenotype | 0.24221591 |
| 147 | MP0005376_homeostasis/metabolism_phenot | 0.23818355 |
| 148 | MP0003935_abnormal_craniofacial_develop | 0.23033736 |
| 149 | MP0002295_abnormal_pulmonary_circulatio | 0.22876725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.18336032 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 6.93160306 |
| 3 | Ventricular tachycardia (HP:0004756) | 6.56665753 |
| 4 | Atrial fibrillation (HP:0005110) | 6.52639705 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 6.45421985 |
| 6 | Primary atrial arrhythmia (HP:0001692) | 6.07909456 |
| 7 | Supraventricular tachycardia (HP:0004755) | 5.89748560 |
| 8 | Supraventricular arrhythmia (HP:0005115) | 5.75025506 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.74173212 |
| 10 | Lipoatrophy (HP:0100578) | 5.69274555 |
| 11 | Exercise-induced myalgia (HP:0003738) | 5.65594330 |
| 12 | Subaortic stenosis (HP:0001682) | 4.92540493 |
| 13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.92540493 |
| 14 | Myoglobinuria (HP:0002913) | 4.86268381 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 4.80489167 |
| 16 | Dilated cardiomyopathy (HP:0001644) | 4.51210274 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 4.41723782 |
| 18 | Syncope (HP:0001279) | 4.36498180 |
| 19 | Palpitations (HP:0001962) | 4.27468058 |
| 20 | Prolonged QT interval (HP:0001657) | 4.24598820 |
| 21 | Hyporeflexia of lower limbs (HP:0002600) | 4.07138949 |
| 22 | Acute necrotizing encephalopathy (HP:0006965) | 4.06099285 |
| 23 | Ventricular arrhythmia (HP:0004308) | 4.05011849 |
| 24 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.93490247 |
| 25 | Rhabdomyolysis (HP:0003201) | 3.93287705 |
| 26 | Mesangial abnormality (HP:0001966) | 3.68928262 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 3.55886051 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.54389726 |
| 29 | Muscle fiber splitting (HP:0003555) | 3.44516441 |
| 30 | Anomalous pulmonary venous return (HP:0010772) | 3.44015440 |
| 31 | Hepatic necrosis (HP:0002605) | 3.35921594 |
| 32 | Acute encephalopathy (HP:0006846) | 3.30895964 |
| 33 | Heart block (HP:0012722) | 3.30878001 |
| 34 | Progressive macrocephaly (HP:0004481) | 3.29672834 |
| 35 | Atrioventricular block (HP:0001678) | 3.29402761 |
| 36 | Hypoplastic left heart (HP:0004383) | 3.28563323 |
| 37 | Bundle branch block (HP:0011710) | 3.27939879 |
| 38 | Distal lower limb muscle weakness (HP:0009053) | 3.20714115 |
| 39 | Aplasia of the musculature (HP:0100854) | 3.17521992 |
| 40 | Mitochondrial inheritance (HP:0001427) | 3.16101981 |
| 41 | Left ventricular hypertrophy (HP:0001712) | 3.15682406 |
| 42 | Ventricular fibrillation (HP:0001663) | 3.14772936 |
| 43 | Abnormal EKG (HP:0003115) | 3.12208723 |
| 44 | Bradycardia (HP:0001662) | 3.11847652 |
| 45 | Exercise intolerance (HP:0003546) | 3.11815759 |
| 46 | Abnormal atrioventricular conduction (HP:0005150) | 3.06640346 |
| 47 | Increased CSF lactate (HP:0002490) | 3.03946744 |
| 48 | Pheochromocytoma (HP:0002666) | 3.02018649 |
| 49 | Ragged-red muscle fibers (HP:0003200) | 3.01302648 |
| 50 | Congenital malformation of the right heart (HP:0011723) | 2.91030327 |
| 51 | Double outlet right ventricle (HP:0001719) | 2.91030327 |
| 52 | Abnormality of the pulmonary veins (HP:0011718) | 2.91003675 |
| 53 | Palmoplantar keratoderma (HP:0000982) | 2.87488529 |
| 54 | Cerebral edema (HP:0002181) | 2.84446572 |
| 55 | Abnormality of glycolysis (HP:0004366) | 2.82665090 |
| 56 | Increased serum pyruvate (HP:0003542) | 2.82665090 |
| 57 | Conjunctival hamartoma (HP:0100780) | 2.82136448 |
| 58 | Hypoglycemic coma (HP:0001325) | 2.81180872 |
| 59 | Hepatocellular necrosis (HP:0001404) | 2.76261758 |
| 60 | Patent foramen ovale (HP:0001655) | 2.72822407 |
| 61 | Neuroendocrine neoplasm (HP:0100634) | 2.72679013 |
| 62 | Neoplasm of the adrenal gland (HP:0100631) | 2.71323651 |
| 63 | Truncus arteriosus (HP:0001660) | 2.59871076 |
| 64 | Hypoplastic heart (HP:0001961) | 2.50338635 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48673391 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.48673391 |
| 67 | Lactic acidosis (HP:0003128) | 2.41667135 |
| 68 | Ketoacidosis (HP:0001993) | 2.39714156 |
| 69 | Decreased circulating renin level (HP:0003351) | 2.39628018 |
| 70 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.33228166 |
| 71 | Respiratory failure (HP:0002878) | 2.32659919 |
| 72 | Myotonia (HP:0002486) | 2.29529852 |
| 73 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.28342005 |
| 74 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.28342005 |
| 75 | Myokymia (HP:0002411) | 2.27977246 |
| 76 | Abnormality of the foot musculature (HP:0001436) | 2.24670391 |
| 77 | Generalized aminoaciduria (HP:0002909) | 2.23989755 |
| 78 | Lipid accumulation in hepatocytes (HP:0006561) | 2.22406911 |
| 79 | Increased connective tissue (HP:0009025) | 2.20856654 |
| 80 | Diaphragmatic weakness (HP:0009113) | 2.20321273 |
| 81 | Increased muscle lipid content (HP:0009058) | 2.18494846 |
| 82 | Partial duplication of thumb phalanx (HP:0009944) | 2.16346885 |
| 83 | Glycosuria (HP:0003076) | 2.14713928 |
| 84 | Abnormality of urine glucose concentration (HP:0011016) | 2.14713928 |
| 85 | Congestive heart failure (HP:0001635) | 2.13432139 |
| 86 | Proximal tubulopathy (HP:0000114) | 2.13067365 |
| 87 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.12726787 |
| 88 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.12103979 |
| 89 | Nausea (HP:0002018) | 2.11287824 |
| 90 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.10642750 |
| 91 | Neck muscle weakness (HP:0000467) | 2.09701500 |
| 92 | Increased intramyocellular lipid droplets (HP:0012240) | 2.09538899 |
| 93 | Increased hepatocellular lipid droplets (HP:0006565) | 2.08527059 |
| 94 | Increased variability in muscle fiber diameter (HP:0003557) | 2.08033581 |
| 95 | Generalized muscle weakness (HP:0003324) | 2.04893186 |
| 96 | Rimmed vacuoles (HP:0003805) | 2.03557578 |
| 97 | Abnormality of the vocal cords (HP:0008777) | 2.03523842 |
| 98 | Testicular atrophy (HP:0000029) | 2.03092073 |
| 99 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.02746619 |
| 100 | Areflexia of lower limbs (HP:0002522) | 2.02733244 |
| 101 | Increased serum lactate (HP:0002151) | 2.01184435 |
| 102 | Ependymoma (HP:0002888) | 1.99294003 |
| 103 | Pulmonary artery stenosis (HP:0004415) | 1.98978989 |
| 104 | Renal cortical cysts (HP:0000803) | 1.96878647 |
| 105 | Periauricular skin pits (HP:0100277) | 1.95476662 |
| 106 | Preauricular pit (HP:0004467) | 1.95476662 |
| 107 | Foot dorsiflexor weakness (HP:0009027) | 1.94308528 |
| 108 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.93657896 |
| 109 | Limb hypertonia (HP:0002509) | 1.93650757 |
| 110 | Distal lower limb amyotrophy (HP:0008944) | 1.93565092 |
| 111 | Muscle stiffness (HP:0003552) | 1.91742047 |
| 112 | Intestinal atresia (HP:0011100) | 1.89812447 |
| 113 | Ketosis (HP:0001946) | 1.89329869 |
| 114 | Resting tremor (HP:0002322) | 1.88516901 |
| 115 | Tinnitus (HP:0000360) | 1.87640270 |
| 116 | Hemiparesis (HP:0001269) | 1.86551361 |
| 117 | EMG: neuropathic changes (HP:0003445) | 1.85527433 |
| 118 | Hyperthyroidism (HP:0000836) | 1.85264186 |
| 119 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.85263392 |
| 120 | Transposition of the great arteries (HP:0001669) | 1.85263392 |
| 121 | Abnormal connection of the cardiac segments (HP:0011545) | 1.85263392 |
| 122 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.84052408 |
| 123 | Abnormality of the tricuspid valve (HP:0001702) | 1.83685721 |
| 124 | Optic disc pallor (HP:0000543) | 1.80736752 |
| 125 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.76019833 |
| 126 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.73880233 |
| 127 | Partial duplication of the phalanx of hand (HP:0009999) | 1.69389133 |
| 128 | Bulbar palsy (HP:0001283) | 1.68026968 |
| 129 | Poor suck (HP:0002033) | 1.66670137 |
| 130 | X-linked dominant inheritance (HP:0001423) | 1.65403843 |
| 131 | 3-Methylglutaconic aciduria (HP:0003535) | 1.61755401 |
| 132 | Atrioventricular canal defect (HP:0006695) | 1.60828734 |
| 133 | Sudden cardiac death (HP:0001645) | 1.57542799 |
| 134 | Complete atrioventricular canal defect (HP:0001674) | 1.56662290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.99868646 |
| 2 | MYLK | 6.07470673 |
| 3 | STK24 | 4.52820419 |
| 4 | TTN | 3.93790130 |
| 5 | LMTK2 | 3.50392410 |
| 6 | MAPKAPK3 | 3.41724412 |
| 7 | PKN2 | 3.25582408 |
| 8 | PIK3CA | 3.15600176 |
| 9 | ZAK | 2.98200188 |
| 10 | STK38L | 2.49732579 |
| 11 | PDK4 | 2.37676353 |
| 12 | PDK3 | 2.37676353 |
| 13 | WNK3 | 2.37254276 |
| 14 | MUSK | 2.32308817 |
| 15 | IRAK2 | 2.29756352 |
| 16 | PHKG1 | 2.20776060 |
| 17 | PHKG2 | 2.20776060 |
| 18 | BCKDK | 2.20074548 |
| 19 | NEK1 | 1.87154146 |
| 20 | DMPK | 1.85274282 |
| 21 | CDC42BPA | 1.82869010 |
| 22 | MAP2K7 | 1.78691736 |
| 23 | MST4 | 1.73405490 |
| 24 | TIE1 | 1.63002708 |
| 25 | FLT3 | 1.58710127 |
| 26 | ILK | 1.56575466 |
| 27 | NTRK3 | 1.46359929 |
| 28 | PDK2 | 1.44422545 |
| 29 | STK16 | 1.44327499 |
| 30 | PIM2 | 1.39860628 |
| 31 | PAK3 | 1.38514742 |
| 32 | TRPM7 | 1.33502149 |
| 33 | LIMK1 | 1.31531445 |
| 34 | DAPK3 | 1.28105069 |
| 35 | ARAF | 1.25471236 |
| 36 | GRK1 | 1.22425604 |
| 37 | STK4 | 1.21130783 |
| 38 | MAP3K4 | 1.20144524 |
| 39 | PINK1 | 1.13066363 |
| 40 | TRIB3 | 1.12809078 |
| 41 | MAP3K3 | 1.11107476 |
| 42 | MAP2K3 | 1.09644934 |
| 43 | ROCK1 | 1.09176787 |
| 44 | PRKD3 | 1.06993597 |
| 45 | CCNB1 | 1.06289277 |
| 46 | PBK | 1.03853208 |
| 47 | MAP4K2 | 1.02579418 |
| 48 | ERBB4 | 1.01643045 |
| 49 | EPHA3 | 0.98843801 |
| 50 | CAMK2D | 0.97682106 |
| 51 | PRKD1 | 0.94203726 |
| 52 | MARK1 | 0.93510238 |
| 53 | PRKCG | 0.93076879 |
| 54 | GRK7 | 0.90784396 |
| 55 | ERBB2 | 0.81174037 |
| 56 | CAMK1 | 0.80658120 |
| 57 | CASK | 0.79283799 |
| 58 | PTK2B | 0.75796599 |
| 59 | NTRK2 | 0.73606116 |
| 60 | MARK3 | 0.71938173 |
| 61 | TESK1 | 0.65688717 |
| 62 | SGK1 | 0.63758204 |
| 63 | RIPK4 | 0.59321433 |
| 64 | MAP3K5 | 0.59142445 |
| 65 | SGK223 | 0.58942394 |
| 66 | SGK494 | 0.58942394 |
| 67 | DAPK2 | 0.58513035 |
| 68 | CAMK2A | 0.58234106 |
| 69 | AKT3 | 0.57736311 |
| 70 | WNK4 | 0.56652138 |
| 71 | EPHB1 | 0.55940181 |
| 72 | PKN1 | 0.55685817 |
| 73 | PRKCI | 0.55419443 |
| 74 | STK3 | 0.55352204 |
| 75 | ROCK2 | 0.55298026 |
| 76 | MAP3K6 | 0.53914635 |
| 77 | MAP2K4 | 0.53466319 |
| 78 | RPS6KC1 | 0.53008169 |
| 79 | RPS6KL1 | 0.53008169 |
| 80 | CAMK4 | 0.52139498 |
| 81 | FRK | 0.51132954 |
| 82 | PRKAA1 | 0.50546262 |
| 83 | MINK1 | 0.50223795 |
| 84 | MAPK13 | 0.50147428 |
| 85 | RPS6KA1 | 0.49258209 |
| 86 | KDR | 0.49142862 |
| 87 | PRKG2 | 0.48609083 |
| 88 | FGFR1 | 0.48295373 |
| 89 | NUAK1 | 0.48157458 |
| 90 | MAPK12 | 0.47517527 |
| 91 | PRKACB | 0.47460479 |
| 92 | PRKCE | 0.46954271 |
| 93 | DAPK1 | 0.45236174 |
| 94 | TLK1 | 0.44029928 |
| 95 | FGFR4 | 0.43975041 |
| 96 | PRKAA2 | 0.43025471 |
| 97 | ADRBK2 | 0.41855949 |
| 98 | RPS6KA6 | 0.40554812 |
| 99 | SGK3 | 0.40241023 |
| 100 | PRKCA | 0.40110930 |
| 101 | RPS6KA3 | 0.38817000 |
| 102 | TGFBR2 | 0.38697391 |
| 103 | CSNK1G3 | 0.38494177 |
| 104 | TGFBR1 | 0.38310668 |
| 105 | CSNK1G1 | 0.35977511 |
| 106 | BMX | 0.35487648 |
| 107 | CSNK1G2 | 0.34923595 |
| 108 | PRKACA | 0.34747829 |
| 109 | CSNK1E | 0.34627840 |
| 110 | MAP2K6 | 0.34587350 |
| 111 | PRKG1 | 0.32487352 |
| 112 | UHMK1 | 0.32144520 |
| 113 | PRKCH | 0.32109477 |
| 114 | INSRR | 0.29957105 |
| 115 | WNK1 | 0.26366911 |
| 116 | BRSK2 | 0.25900653 |
| 117 | NEK9 | 0.25781457 |
| 118 | PAK2 | 0.25596875 |
| 119 | CAMK2G | 0.24314505 |
| 120 | EPHB2 | 0.23534160 |
| 121 | PRKCQ | 0.22494691 |
| 122 | PRKACG | 0.22418268 |
| 123 | MET | 0.21191633 |
| 124 | STK39 | 0.19257597 |
| 125 | MAPKAPK2 | 0.18745727 |
| 126 | AKT2 | 0.18742429 |
| 127 | BCR | 0.16863200 |
| 128 | LATS2 | 0.16167411 |
| 129 | AURKB | 0.15733939 |
| 130 | MAP3K7 | 0.13887115 |
| 131 | DYRK2 | 0.13569691 |
| 132 | TYK2 | 0.13468975 |
| 133 | EGFR | 0.13412767 |
| 134 | NME2 | 0.12163993 |
| 135 | MAPK11 | 0.12077549 |
| 136 | MAP3K11 | 0.09728188 |
| 137 | STK38 | 0.09508785 |
| 138 | CAMK1D | 0.09367305 |
| 139 | BRSK1 | 0.09058610 |
| 140 | CDK4 | 0.06277913 |
| 141 | PLK2 | 0.06139032 |
| 142 | SGK2 | 0.05710133 |
| 143 | ADRBK1 | 0.04922203 |
| 144 | RIPK1 | 0.04807204 |
| 145 | FER | 0.04769850 |
| 146 | MAP2K1 | 0.04758745 |
| 147 | PDK1 | 0.04732665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.68895382 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 5.52659771 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 4.30125343 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.16822553 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.67718897 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.64720382 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.56808819 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 3.01428996 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.92562137 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.63279719 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.60747692 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.52351380 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.48494043 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.15745971 |
| 15 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.99811522 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.89142819 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.83711895 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.81130845 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.79647979 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.76059390 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70555586 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.70118560 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69160450 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.65591150 |
| 25 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.47489438 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.47187413 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45812769 |
| 28 | Morphine addiction_Homo sapiens_hsa05032 | 1.45555926 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45417263 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42796287 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.40514403 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.34635349 |
| 33 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.02463136 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.02135094 |
| 35 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.01603204 |
| 36 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.00723639 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00355157 |
| 38 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.98759180 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98595813 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94710677 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93839179 |
| 42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93523434 |
| 43 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93303696 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91168340 |
| 45 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.87372058 |
| 46 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86024240 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.84408133 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84032933 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82152195 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 0.80615879 |
| 51 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77022587 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75952447 |
| 53 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75311061 |
| 54 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75219888 |
| 55 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.73314970 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71943796 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68988236 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66471064 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65628377 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64080556 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 0.63072990 |
| 62 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62813661 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62470283 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.59598698 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58656047 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.56733855 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56663752 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55366354 |
| 69 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54296262 |
| 70 | Nicotine addiction_Homo sapiens_hsa05033 | 0.52808389 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49287029 |
| 72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49229514 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.49187774 |
| 74 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49132827 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.48055963 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47760743 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47642121 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47470334 |
| 79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46798684 |
| 80 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45417904 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.45191720 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44135805 |
| 83 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.43358302 |
| 84 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41068534 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38858185 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38569588 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37497657 |
| 88 | Protein export_Homo sapiens_hsa03060 | 0.37329047 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.36730077 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36436733 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35402164 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34417861 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34338580 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.33205433 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31708841 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31577071 |
| 97 | Adherens junction_Homo sapiens_hsa04520 | 0.31308647 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30869077 |
| 99 | Gap junction_Homo sapiens_hsa04540 | 0.30668937 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30225376 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30207112 |
| 102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.29687944 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.24612343 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.23439249 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22501550 |
| 106 | Mismatch repair_Homo sapiens_hsa03430 | 0.20602230 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.17903621 |
| 108 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16912512 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.16757407 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.16492429 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.13696098 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13601179 |
| 113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.12706086 |
| 114 | Circadian entrainment_Homo sapiens_hsa04713 | 0.11163999 |
| 115 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.10961303 |
| 116 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.10714200 |
| 117 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.09248229 |
| 118 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.09140537 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.08738608 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.08219697 |
| 121 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.08037743 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.05749116 |
| 123 | Renin secretion_Homo sapiens_hsa04924 | 0.05677045 |
| 124 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.04397672 |
| 125 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.03421932 |
| 126 | Melanogenesis_Homo sapiens_hsa04916 | 0.02053588 |
| 127 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.01855103 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | -0.0774574 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0753706 |
| 130 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | -0.0714385 |
| 131 | Homologous recombination_Homo sapiens_hsa03440 | -0.0699369 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | -0.0648861 |
| 133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | -0.0646575 |
| 134 | Taste transduction_Homo sapiens_hsa04742 | -0.0568975 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0533490 |
| 136 | Ribosome_Homo sapiens_hsa03010 | -0.0531591 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | -0.0373941 |
| 138 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0306208 |
| 139 | RNA polymerase_Homo sapiens_hsa03020 | -0.0250032 |
| 140 | Insulin secretion_Homo sapiens_hsa04911 | -0.0227561 |

